A Bold Call on Biotech ETFs

The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotechnology exchange traded fund, is off 8.4% over the past week. While that is not the official definition of a correction, a 10% decline is needed for a security to enter correction territory, acute weakness in IBB and rival...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.